HENWOOD GERALDINE (President and CEO) received a stock award from BAUDAX BIO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/22/2021ACC: 0001192482-21-000104
DirectorOfficer· President and CEO
Since Nov 2019
+65.44K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
65.44K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+65.44K
Price / share
—
Trade value
—
% of position
23.0%
1/20/2021
284.87K→350.31K
Total
Net shares
+65.44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2021 | A · Award | +65.44K | — | — | 23.0% | 284.87K | 350.31K |
| Total | +65.44K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20K
Total
20K indirect20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Indirect |
| Total | 20K | 20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported